In late October, we unveiled the CAFC Intelligence Report 2023, a comprehensive analysis encompassing stakeholders before the Court of... Read More
Written by: Susan M. Janicki, Ph.D. & Agnes Juang, Ph.D. The Federal Trade Commission (FTC) issued a policy statement[1] on September... Read More
Written by: Alexander D. Zeng & Philip M. Nelson On October 5, 2023, the World Intellectual Property Organization published Cast21’s PCT application related to... Read More
The Patent Trial and Appeal Board (PTAB) holds a pivotal position within intellectual property law, wielding substantial influence over patent... Read More
Written by: Jason J. Jardine
On October 27th, 2023, the U.S. Food and Drug Administration (FDA) approved LOQTORZITM (toripalimab-tpzi), developed by Coherus... Read More
Written by: Susan M. Janicki, Ph.D. & Agnes Juang, Ph.D.
The Federal Trade Commission (FTC) issued a policy statement[1] on September 14,... Read More
Written by: Alexander D. Zeng & Philip M. Nelson
On October 5, 2023, the World Intellectual Property Organization published Cast21’s PCT application related to its... Read More
The Patent Trial and Appeal Board (PTAB) holds a pivotal position within intellectual property law, wielding substantial influence over patent... Read More
Written by: Jason J. Jardine
On October 27th, 2023, the U.S. Food and Drug Administration (FDA) approved LOQTORZITM (toripalimab-tpzi), developed by Coherus... Read More
Written by: Susan M. Janicki, Ph.D. & Agnes Juang, Ph.D.
The Federal Trade Commission (FTC) issued a policy statement[1] on September 14,... Read More
Written by: Alexander D. Zeng & Philip M. Nelson
On October 5, 2023, the World Intellectual Property Organization published Cast21’s PCT application related to its... Read More
The Patent Trial and Appeal Board (PTAB) holds a pivotal position within intellectual property law, wielding substantial influence over patent... Read More
Written by: Jason J. Jardine
On October 27th, 2023, the U.S. Food and Drug Administration (FDA) approved LOQTORZITM (toripalimab-tpzi), developed by Coherus... Read More